back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-10-16 12:48 Tx date 2025-05-20 |
$RX
BioSyent Inc. |
gowd, prakash
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-10-02 09:18 Tx date 2025-09-30 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$6,554
+568 vol $11.54 each |
180,147 | |
| Filed 2025-10-02 09:17 Tx date 2025-09-30 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-1,137 vol |
179,579 | |
| Filed 2025-10-01 10:53 Tx date 2025-09-30 |
$RX
BioSyent Inc. |
Elford, Sara
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
$3,023
+262 vol $11.54 each |
10,229 | |
| Filed 2025-10-01 10:51 Tx date 2025-09-30 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,615
+140 vol $11.54 each |
13,133 | |
| Filed 2025-10-01 10:50 Tx date 2025-09-30 |
$RX
BioSyent Inc. |
Elford, Sara
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-524 vol |
9,967 | |
| Filed 2025-10-01 10:50 Tx date 2025-09-30 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-281 vol |
12,993 | |
| Filed 2025-07-06 12:08 Tx date 2025-06-30 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$6,678
+566 vol $11.80 each |
180,716 | |
| Filed 2025-07-06 12:06 Tx date 2025-06-30 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
-1,132 vol |
180,150 | |
| Filed 2025-07-04 08:19 Tx date 2025-06-30 |
$RX
BioSyent Inc. |
Elford, Sara
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$3,079
+261 vol $11.80 each |
15,672 | |
| Filed 2025-07-04 08:17 Tx date 2025-06-30 |
$RX
BioSyent Inc. |
Elford, Sara
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-522 vol |
10,491 | |
| Filed 2025-07-03 03:35 Tx date 2025-06-30 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,652
+140 vol $11.80 each |
13,274 | |
| Filed 2025-07-03 03:34 Tx date 2025-06-30 |
$RX
BioSyent Inc. |
Arcuri, Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+280 vol |
13,134 | |
| Filed 2025-06-17 16:24 Tx date 2025-06-12 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-11,990
-1,000 vol $11.99 each |
59,147 | |
| Filed 2025-06-06 08:51 Tx date 2025-06-05 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-22,325
-1,900 vol $11.75 each |
60,147 | |
| Filed 2025-06-06 08:50 Tx date 2025-06-02 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-56,165
-4,700 vol $11.95 each |
62,047 | |
| Filed 2025-05-26 08:21 Tx date 2025-05-23 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-5,975
-500 vol $11.95 each |
66,747 | |
| Filed 2025-05-26 08:21 Tx date 2025-05-23 |
$RX
BioSyent Inc. |
Wilson, Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$-1,165
-100 vol $11.65 each |
67,247 | |
| Filed 2025-05-23 16:08 Tx date 2025-05-23 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,390
-200 vol $11.95 each |
181,282 | |
| Filed 2025-05-23 16:07 Tx date 2025-05-23 |
$RX
BioSyent Inc. |
Lockhard, Peter Douglas
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-751.59
-63 vol $11.93 each |
181,482 |